Results 171 to 180 of about 1,179,472 (345)
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham +21 more
wiley +1 more source
Exploring the genomic resources of seven domestic Bactrian camel populations in China through restriction site-associated DNA sequencing. [PDF]
Liu C, Chen H, Yang X, Zhang C, Ren Z.
europepmc +1 more source
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts +8 more
wiley +1 more source
RADSex: A computational workflow to study sex determination using restriction site-associated DNA sequencing data. [PDF]
Feron R +35 more
europepmc +1 more source
Site-specific gene manipulation of fluorescent proteins using artificial restriction DNA cutter [PDF]
Hitoshi Katada +3 more
openalex +1 more source
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira +14 more
wiley +1 more source
Development of 23 novel microsatellite markers of Amomum tsao-ko (Zingiberaceae) based on restriction-site-associated DNA sequencing. [PDF]
Lu B +6 more
europepmc +1 more source
Machine Learning Applications to DNA Subsequence and Restriction Site Analysis [PDF]
Ethan Jacob Moyer, Anup Das
openalex +1 more source

